Molecular genetic analysis and clinical consideration of two families with GCK gene mutation

Abstract

Abstract: Objective To explore the molecular genetics and clinical characteristics of two cases of maturity-onset diabetes of the young (MODY) type 2 caused by glucokinase (GCK) gene mutation. Methods Two patients who were admitted into Beijing Jishuitan Hospital with suspected diagnosis of MODY from April 2015 to December 2015 were collected and analyzed by their clinical data. GCK gene sequencing was carried out for the two patients and their family members to find the cause of their disease. Results A new GCK heterozygous mutation p.T82P (c.244 A ＞ C) and a reported GCK heterozygous mutation p.V412M (c.1234 G ＞ A) were found in the two families. In the aspect of clinical manifestations, in addition to stable hyperglycemia, the 3 GCK gene mutation carriers in the two families showed metabolic syndrome of varying degrees. Conclusions GCK gene mutation p.T82P may be the cause of MODY2. The clinical manifestations of GCK gene mutation carriers are complex, and they need to be individualized and managed in treatment and prognosis.

Key words: maturity-onset diabetes of the young, glucokinase, gene mutation

CLC Number:

WANG Zhi-xin, ZUO Qing-yao, LI Wei, CHEN Jia, DENG Wei. Molecular genetic analysis and clinical consideration of two families with GCK gene mutation[J]. Basic & Clinical Medicine, 2020, 40(12): 1640-1644.

References

[1] Wang Z, Ping F, Zhang Q, et al. Preliminary screening of mutations in the glucokinase gene of Chinese patients with gestational diabetes[J]. J Diabetes Invest, 2018, 9: 199-203.
[2] 王志新,平凡,张茜,等. 中国妊娠期血糖异常人群葡萄糖激酶基因突变初步筛查[J]. 中华糖尿病杂志, 2014, 6: 397-401.
[3] Osbak K, Colclough K, Saint-Martin C, et al. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia[J]. Hum Mutat, 2009, 30: 1512-1526.
[4] Marotta D, Anand G, Anderson T, et al. Identification and characterization of the ATP-binding site in human pancreatic glucokinase[J]. Arch Biochem Biophys, 2005, 436: 23-31.
[5] Marks S, Couch R. Identification of two new mutations in the glucokinase gene that result in maturity-onset diabetes of the young[J]. Diabetes Care, 2010, 33: e94. doi: 10.2337/dc10-0685.
[6] Estalella I, Rica I, Perez De Nanclares G, et al. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain[J]. Clin Endocrinol (Oxf), 2007, 67: 538. doi: 10.1111/j.1365-2265.2007.02921.x.
[7] 王志新,于淼,郑佳,等. 四例中国青少年的成人起病型糖尿病2型家系的临床与分子遗传学研究[J]. 中华糖尿病杂志, 2014, 6: 21-26.
[8] Wang Z, Diao C, Liu Y, et al. Identification and functional analysis of GCK gene mutations in 12 Chinese families with hyperglycemia[J]. J Diabetes Invest, 2019, 10: 963-971.
[9] Thanabalasingham G, Owen K. Diagnosis and manage-ment of maturity onset diabetes of the young (MODY)[J]. BMJ, 2011, 343: d6044. doi: 10.1136/bmj.d6044.
[10] Stride A, Vaxillaire M, Tuomi T, et al. The genetic abnormality in the beta cell determines the response to an oral glucose load[J]. Diabetologia, 2002, 45: 427-435.
[11] Stoffel M, Bell K, Blackburn C, et al. Identification of glucokinase mutations in subjects with gestational diabetes mellitus[J]. Diabetes, 1993, 42: 937-940.
[12] Ellard S, Bellanne-Chantelot C, Hattersley A. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young[J]. Diabetologia, 2008, 51: 546-553.
[13] Steele A, Shields B, Wensley K, et al. Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia[J]. JAMA, 2014, 311: 279-286.
[14] Fendler W, Malachowska B, Baranowska-Jazwiecka A, et al. Population-based estimates for double diabetes amongst people with glucokinase monogenic diabetes, GCK-MODY[J]. Diabet Med, 2014, 31: 881-883.
[15] Liu L, Liu Y, Ge X, et al. Insights into pathogenesis of five novel GCK mutations identified in Chinese MODY patients[J]. Metabolism, 2018, 89: 8-17.
[16] Martin D, Bellanne-Chantelot C, Deschamps I, et al. Long-term follow-up of oral glucose tolerance test-derived glucose tolerance and insulin secretion and insulin sensitivity indexes in subjects with glucokinase mutations (MODY2)[J]. Diabetes Care, 2008, 31: 1321-1323.
[17] Spegel P, Ekholm E, Tuomi T, et al. Metabolite profiling reveals normal metabolic control in carriers of mutations in the glucokinase gene (MODY2)[J]. Diabetes, 2013, 62: 653-661.